114 related articles for article (PubMed ID: 9782221)
1. Dirithromycin concentrations in bronchial mucosa and secretions.
Leroyer C; Muller-Serieys C; Quiot J; Benhamou D; Clavier J; Bergogne-Bérézin E
Respiration; 1998; 65(5):381-5. PubMed ID: 9782221
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis.
Cazzola M; Matera MG; Tufano MA; Polverino M; Catalanotti P; Varanese L; Rossi F
Pulm Pharmacol; 1994 Dec; 7(6):377-81. PubMed ID: 7549225
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.
Matera MG; Tufano MA; Polverino M; Rossi F; Cazzola M
Eur Respir J; 1997 Jan; 10(1):98-103. PubMed ID: 9032500
[TBL] [Abstract][Full Text] [Related]
4. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution of dirithromycin: comparison with erythromycin.
Bergogne-Bérézin E
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314
[TBL] [Abstract][Full Text] [Related]
6. Serum, sputum and bronchial concentrations of erythromycin in chronic bronchitis after single and multiple treatments with either propionate-N-acetylcysteinate or stearate erythromycin.
Ricevuti G; Pasotti D; Mazzone A; Gazzani G; Fregnan GB
Chemotherapy; 1988; 34(5):374-9. PubMed ID: 3180905
[TBL] [Abstract][Full Text] [Related]
7. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Hosie J; Quinn P; Smits P; Sides G
J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of ceftibuten in bronchial secretions.
Scaglione F; Triscari F; Demartini G; Arcidiacono M; Cocuzza C; Fraschini F
Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
Sides GD
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary penetration of ceftazidime.
Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
[TBL] [Abstract][Full Text] [Related]
12. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
Gaillat J
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
[TBL] [Abstract][Full Text] [Related]
13. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters.
Thompson AB; Daughton D; Robbins RA; Ghafouri MA; Oehlerking M; Rennard SI
Am Rev Respir Dis; 1989 Dec; 140(6):1527-37. PubMed ID: 2604284
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of dirithromycin versus miocamycin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis.
Pozzi E
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():153-8. PubMed ID: 8478306
[TBL] [Abstract][Full Text] [Related]
15. [The comparative pharmacokinetics of ceftriaxone in the blood and bronchial secretion in patients with different durations in the course of chronic bronchitis].
Kamnev IuV; Manuĭlov KK; Orlov VA
Antibiot Khimioter; 1991 Jun; 36(6):48-50. PubMed ID: 1898191
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline concentrations in lung tissue, bronchial wall, and bronchial secretions.
Gartmann J
Chemotherapy; 1975; 21 Suppl 1():19-26. PubMed ID: 1157579
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin concentrations at the sites of pulmonary infection.
Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
Eur Respir J; 1990 Sep; 3(8):886-90. PubMed ID: 1963411
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
Kamnev IuV; Manuĭlov KK; Orlov VA; Sokolova VI
Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
[TBL] [Abstract][Full Text] [Related]
19. A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease.
Cazzola M; Caputi M; Santangelo G; Diu Vinciguerra A; Perna FD; Polverino M
J Chemother; 1997 Aug; 9(4):279-84. PubMed ID: 9269609
[TBL] [Abstract][Full Text] [Related]
20. Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions.
Bergogne-Bérézin E; Berthelot G; Kafé HP; Dournovo P
Int J Clin Pharmacol Res; 1985; 5(5):341-4. PubMed ID: 4066084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
